JP2023527358A5 - - Google Patents

Info

Publication number
JP2023527358A5
JP2023527358A5 JP2022572568A JP2022572568A JP2023527358A5 JP 2023527358 A5 JP2023527358 A5 JP 2023527358A5 JP 2022572568 A JP2022572568 A JP 2022572568A JP 2022572568 A JP2022572568 A JP 2022572568A JP 2023527358 A5 JP2023527358 A5 JP 2023527358A5
Authority
JP
Japan
Prior art keywords
pulmonary fibrosis
pharmaceutical composition
salt
formula
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022572568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527358A (ja
JP7745571B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/050457 external-priority patent/WO2021237273A1/en
Publication of JP2023527358A publication Critical patent/JP2023527358A/ja
Publication of JP2023527358A5 publication Critical patent/JP2023527358A5/ja
Application granted granted Critical
Publication of JP7745571B2 publication Critical patent/JP7745571B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022572568A 2020-05-28 2021-05-17 肺線維症を処置する方法 Active JP7745571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020901743A AU2020901743A0 (en) 2020-05-28 Methods of treating pulmonary fibrosis
AU2020901743 2020-05-28
PCT/AU2021/050457 WO2021237273A1 (en) 2020-05-28 2021-05-17 Methods of treating pulmonary fibrosis

Publications (3)

Publication Number Publication Date
JP2023527358A JP2023527358A (ja) 2023-06-28
JP2023527358A5 true JP2023527358A5 (cg-RX-API-DMAC7.html) 2024-05-14
JP7745571B2 JP7745571B2 (ja) 2025-09-29

Family

ID=78745664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022572568A Active JP7745571B2 (ja) 2020-05-28 2021-05-17 肺線維症を処置する方法

Country Status (7)

Country Link
EP (1) EP4157278A4 (cg-RX-API-DMAC7.html)
JP (1) JP7745571B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230017843A (cg-RX-API-DMAC7.html)
CN (1) CN115867281A (cg-RX-API-DMAC7.html)
AU (1) AU2021279205B2 (cg-RX-API-DMAC7.html)
CA (1) CA3177652A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021237273A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020245902B2 (en) 2019-03-28 2025-01-02 Amplia Therapeutics Limited A salt and crystal form of a FAK inhibitor
WO2023139154A1 (en) * 2022-01-19 2023-07-27 Nordic Bioscience A/S A method for detecting covid-19 in a patient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2675794T3 (da) 2011-02-17 2019-05-06 Cancer Therapeutics Crc Pty Ltd Selektive fak-inhibitorer
WO2014027199A1 (en) * 2012-08-14 2014-02-20 Cancer Therapeutics Crc Pty Ltd Fak and flt3 inhibitors
AU2020245902B2 (en) * 2019-03-28 2025-01-02 Amplia Therapeutics Limited A salt and crystal form of a FAK inhibitor

Similar Documents

Publication Publication Date Title
JP2021063088A5 (cg-RX-API-DMAC7.html)
JP2024540183A5 (cg-RX-API-DMAC7.html)
MX2023000798A (es) Peptidos funcionalizados como agentes antivirales.
MX2023005984A (es) Nuevos agentes antivirales derivados de la espiropirrolidina.
JP2023002662A5 (cg-RX-API-DMAC7.html)
JP2010532373A5 (cg-RX-API-DMAC7.html)
JP2010532372A5 (cg-RX-API-DMAC7.html)
JP2015528471A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
IL314873A (en) Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
JP2015508749A5 (cg-RX-API-DMAC7.html)
PH12021552930A1 (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
JP2008521827A5 (cg-RX-API-DMAC7.html)
JP2020512337A5 (cg-RX-API-DMAC7.html)
JP2019517587A5 (cg-RX-API-DMAC7.html)
JP2016514141A5 (cg-RX-API-DMAC7.html)
JP2010527985A5 (cg-RX-API-DMAC7.html)
JP2019533660A5 (cg-RX-API-DMAC7.html)
JPWO2023195530A5 (cg-RX-API-DMAC7.html)
JP2024531188A5 (cg-RX-API-DMAC7.html)
JPWO2023054732A5 (cg-RX-API-DMAC7.html)
JP2013506004A5 (cg-RX-API-DMAC7.html)
JP2024544538A5 (cg-RX-API-DMAC7.html)
JP2022551691A5 (cg-RX-API-DMAC7.html)